Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Apple
AAPL
|
$552M |
| 2 |
Comcast
CMCSA
|
$389M |
| 3 |
Microsoft
MSFT
|
$365M |
| 4 |
Amazon
AMZN
|
$274M |
| 5 |
Exxon Mobil
XOM
|
$262M |
Top Sells
| 1 |
Canadian National Railway
CNI
|
$89.7M |
| 2 |
SE
Spectra Energy Corp Wi
SE
|
$79.6M |
| 3 |
Suncor Energy
SU
|
$78.1M |
| 4 |
STJ
St Jude Medical
STJ
|
$63.5M |
| 5 |
TC Energy
TRP
|
$58.8M |
Sector Composition
| 1 | Technology | 16.63% |
| 2 | Healthcare | 15% |
| 3 | Consumer Discretionary | 10.63% |
| 4 | Communication Services | 10.47% |
| 5 | Industrials | 10.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
IBM
IBM
$227B
| $598M | 0.74% | 3,434,277 +684,300 | +25% | +$119M |
|
27
Altria Group
MO
$113B
| $535M | 0.67% | 7,486,394 +1,501,400 | +25% | +$107M |
|
28
Oracle
ORCL
$635B
| $497M | 0.62% | 11,137,928 +2,309,400 | +26% | +$103M |
|
29
McDonald's
MCD
$224B
| $474M | 0.59% | 3,653,548 +558,300 | +18% | +$72.4M |
|
30
Medtronic
MDT
$119B
| $440M | 0.55% | 5,459,663 +1,085,400 | +25% | +$87.4M |
|
31
Walmart
WMT
$774B
| $438M | 0.54% | 6,072,429 +1,188,400 | +24% | +$85.7M |
|
32
Amgen
AMGN
$155B
| $432M | 0.54% | 2,636,008 +551,600 | +26% | +$90.5M |
|
33
Mastercard
MA
$538B
| $412M | 0.51% | 3,660,220 +722,600 | +25% | +$81.3M |
|
34
Schlumberger
SLB
$55B
| $409M | 0.51% | 5,241,535 +1,075,000 | +26% | +$84M |
|
35
3M
MMM
$82.8B
| $408M | 0.51% | 2,131,304 +447,900 | +27% | +$85.7M |
|
36
AbbVie
ABBV
$372B
| $375M | 0.47% | 5,758,229 +1,222,400 | +27% | +$79.7M |
|
37
Boeing
BA
$177B
| $367M | 0.46% | 2,077,391 +418,500 | +25% | +$74M |
|
|
CELG
38
DELISTED
Celgene Corp
CELG
| $342M | 0.43% | 2,746,896 +588,000 | +27% | +$73.2M |
|
39
Eli Lilly
LLY
$657B
| $337M | 0.42% | 4,011,443 +781,800 | +24% | +$65.8M |
|
40
Starbucks
SBUX
$100B
| $332M | 0.41% | 5,681,144 +1,099,100 | +24% | +$64.2M |
|
41
Bristol-Myers Squibb
BMY
$96B
| $322M | 0.4% | 5,921,670 +1,267,900 | +27% | +$68.9M |
|
42
Honeywell
HON
$139B
| $320M | 0.4% | 2,565,473 +552,100 | +27% | +$68.9M |
|
|
AGN
43
DELISTED
Allergan plc
AGN
| $318M | 0.4% | 1,329,086 +226,200 | +21% | +$54M |
|
44
Gilead Sciences
GILD
$140B
| $317M | 0.39% | 4,668,124 +989,400 | +27% | +$67.2M |
|
45
Broadcom
AVGO
$1.4T
| $312M | 0.39% | 1,425,613 +323,900 | +29% | +$70.9M |
|
46
Booking.com
BKNG
$181B
| $311M | 0.39% | 174,852 +37,200 | +27% | +$66.2M |
|
47
RTX Corp
RTX
$212B
| $311M | 0.39% | 2,771,721 +557,300 | +25% | +$62.5M |
|
48
Union Pacific
UNP
$133B
| $309M | 0.38% | 2,920,172 +600,300 | +26% | +$63.6M |
|
49
Accenture
ACN
$162B
| $302M | 0.38% | 2,516,617 +479,100 | +24% | +$57.4M |
|
50
CVS Health
CVS
$92.8B
| $300M | 0.37% | 3,826,410 +811,100 | +27% | +$63.7M |
|